Figure 3 | British Journal of Cancer

Figure 3

From: Genetic variation in the GSTM3 promoter confer risk and prognosis of renal cell carcinoma by reducing gene expression

Figure 3

Anchorage-independent growth and invasive potential of ccRCC cell lines 786-O and ACHN with altered expression GSTM3 by transient transfection. *P<0.05, **P<0.01. (AD) Expression levels of GSTM3 in ACHN and 786-O cells after transient transfection with shRNA constructs and TOPO-GSTM3 construct, respectively, as detected by qRT-PCR and western blot. (EH) Invasive potential ACHN and 786-O cells after the transient transfection, as detected by Transwell assay. (IJ) Anchorage-independent growth in ACHN cells after transient transfection with shRNA constructs and TOPO-GSTM3 construct, as detected by the double-layered soft agarose culture system. (K) Background level of GSTM3 expression in ACHN, 786-O and NRCC cells, as detected by western blot.

Back to article page